Paris, France - Enoxaparin (Lovenox, Sanofi-Aventis) seems to be associated with a lower risk of cardiovascular outcomes compared with unfractionated heparin (UFH) in patients with STEMI undergoing ...

There is no gold standard for the prophylaxis of venous thromboembolism (VTE) for patients with acute ischemic stroke because of uncertainty regarding the efficacy of various anticoagulant agents.

The objective of our study was to determine the feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates, and to assess response to treatment. Nineteen premature and ...

In this study, no difference in the rate of CVC-related VTE was detected between patients receiving enoxaparin and patients receiving placebo. The dose of enoxaparin used in this study proved to be ...

It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...

Enoxaparin sodium is a subcutaneously (SC) administered low-molecular-weight heparin approved in the United States for the inpatient or outpatient treatment of deep venous thrombosis (DVT) in place of ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. It is indicated alone or in combination with ...

Patients undergoing primary percutaneous coronary intervention for STEMI derived a greater net benefit on ischemic outcomes when taking enoxaparin vs. unfractionated heparin, new results from a study ...

Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox. The recall issued Tuesday by Apotex, a ...